Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows recruitment as closed ('No longer looking for participants') and introduces new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), along with a page revision note ('Revision: v3.6.0') and a formatting update to the Intervention/Treatment label.
    Difference
    0.5%
    Check dated 2026-06-13T18:11:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.5, indicating a minor page revision. It does not change the page's content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-06-06T14:38:49.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing v3.5.3. This indicates a minor update to the page revision history and does not modify study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-16T09:13:09.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page footer “Revision” value was updated from v3.5.2 to v3.5.3, reflecting a change in the website’s release/version without altering the underlying clinical study information.
    Difference
    0.1%
    Check dated 2026-04-25T05:23:12.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added revision v3.5.2 and removed revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T00:00:03.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added Carcinoma of esophagus as a condition term. Added a Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-03T18:24:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.